Industry Specific
Procedure for Loan Licence to Manufacture Ayurvedic, Siddha, Sowa-Rigpa and Unani Drugs
INTRODUCTION
A loan license is required to manufacture Ayurvedic, Siddha, Sowa-Rigpa and Unani Drugs as it lets the businesses which do not have their own manufacturing facility and resources to legally produce their own products use the infrastructure and the expertise of an already licensed and a Good Manufacturing Practice (GMP) certified manufacturer. This safeguards all the traditional medicines stick to the strict safety, efficacy, and the quality standards which are mandated by the Drugs and Cosmetics Act, 1940 and Drug Rules, 1945.
APPLICABLE PROVISIONS
- Section 3 of Drug and Cosmetic Act, 1940
- Rule 153A,154A,156A,158A of Drug Rules, 1945
MANDATORY DOCUMENTS
- Application in Form 24E
- Company registration certificate and identity/address proof of directors/partners
- Good Manufacturing Practices (GMP) certificate
- Proof of premises (ownership documents or rent/lease agreement)
- Adequate space (minimum 1200 sq. ft.), equipment, and testing facilities to handle the additional production volume.
- List of machinery and equipment.
- Product formulations and a list of drugs to be manufactured
- Details of the quality control lab
- No Objection Certificate (NOC) from the Pollution Control Board, if applicable
- Proof of safety and effectiveness as per Rule 158A of the Drugs & Cosmetics Rules, 1945
PROCESS OF LICENSE
Applicant shall submit Form 24E to obtain licence to manufacture ayurvedic, siddha, sowa-rigpa and unani drugs in through the e-AUSHADHI portal, along with the prescribed fee of rupees three thousand (Rs.3000/-) for the first ten products and after those ten products, an additional fee of rupees two thousand (Rs.2000/-) per product with the required documents; Upon satisfactory inspection of the site is completed after that the state licensing authority (SLA) issues the license through Form 25E.
RENEWAL
Applicant shall submit Form 24E to renew the Licence to Manufacture Ayurvedic, Siddha, Sowa-Rigpa and Unani Drugs.
Tell us how helpful was this post?
Our Solutions
Related Procedures
- Procedure for Loan Licenses to Manufacture for Sale of Drugs in Large Volume Parenteral, Sera and Vaccine and Recombinant DNA (r-DNA) Derived Drugs
- Procedure for Notification and Reorganization of Food Laboratories
- Procedure for Import License for Examination, Test and Analysis
- Procedure for Licence to Manufacture Cosmetics for Sale and Distribution
- Procedure for Drug Licence to Manufacture for Sale or Distribution of Drugs Specified In Schedules C And C(1) And X
- Procedure to Obtain Licence for Sale of Homoeopathic Drugs
- Manufacture of New Drug for Sale or Distribution Approval Process in India
- Procedure for Drug License in any case other than Repacking, Manufacture Drugs other than Specified in Schedules C And C(1) and X
- Procedure for Approval under Category I of the Production Linked Incentive (PLI) Scheme for Food Processing Industry
- Procedure for Drug License in case of Repacking of Drugs Other Than Specified in Schedules C, C(I) and X
